50 likes | 131 Vues
[391 Pages Report] Life Science and Chemical Instrumentation Market research report analyzes geography; forecasting revenues and trends of 2011 – 2016.
E N D
MarketsandMarkets Presents Global Life Science and Chemical Instrumentation Market worth $45.2 Billion by 2016 http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html
The “Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others)” analyzes and studies the major market drivers, restraints, and opportunities in regions such as U.S., Europe, Asia, and Rest of the world. Browse >> 133 data tables. 26 figures. in-depth TOC on Life Science and Chemical Instrumentation Market. http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html Early buyers will receive 10% customization on this report. Request to Download Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=38
The global life science and instrumentation market was estimated to be $30.2 billion in the year 2011 and is expected to grow at a CAGR of 8.4% from 2011 to 2016 to reach $45.2 billion. Spectrometry segment has the largest share (33.8%) followed by chromatography (22%) in the year 2011. The spectrometry market is driven by the coupling of mass spectrometry with chromatography techniques, growing at a CAGR of 7.4% from 2011 to 2016. Research and development is an essential part of life science and chemical industry. In the U.S., $25,101 million PPP (Purchasing Power Parity) was spend on the research and development by the biotechnology firms, in 2010. In the year 2008, the total biotechnology companies were 1,452 in the U.S. and increased by 17% to reach 1,699 in the year 2009. In 2008, 20% of pharmaceuticals were of biological origin, there are currently more than 200 biopharmaceutical drugs available in the market for treating 400 indications, and at the same time, 300 biopharmaceuticals are under clinical trials. These are the major factors driving the market. Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=38
Contact Us Mr. RohanNorth - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252Tel: +1-888-6006-441Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets
About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html